Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients

European Journal of Surgical Oncology

Volumn 34, Issue 6, 2008, Pages 642-647

  Gretschel, S ^a   Astrosini, Ch ^b   Vieth, M ^c   Jons Th ^b   Tomov, T ^a   Hocker M ^b   Schlag, P M ^a   Kemmner, W ^d  

^a Section of Pathology   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c INSTITUTE OF PATHOLOGY   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Bone marrow status; Gastric cancer; Lymph node metastases; VEGF

Indexed keywords

CYTOKERATIN 18; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER RECURRENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; METASTASIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR CELL;

ADULT; AGED; BONE MARROW NEOPLASMS; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 43649088404     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.09.010     Document Type: Article

References (33)

1. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333 26 (1995) 1757-1763
2. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
3. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 6801 (2000) 242-248
4. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82 1 (1990) 4-6
5. Folkman J. Tumour angiogenesis and tissue factor. Nat Med 2 2 (1996) 167-168
6. Liotta L.A. Cancer cell invasion and metastasis. Sci Am 266 2 (1992) 59-62
7. D'Angelica M., Gonen M., Brennan M.F., Turnbull A.D., Bains M., and Karpeh M.S. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240 5 (2004) 808-816
8. Tajima Y., Yamazaki K., Nishino N., et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery - immunohistochemical analysis of 213 lesions. Br J Cancer 91 7 (2004) 1342-1348
9. Fukagawa T., Sasako M., Mann G.B., et al. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 92 4 (2001) 753-760
10. Schlimok G., Funke I., Pantel K., et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 27 11 (1991) 1461-1465
11. Heiss M.M., Allgayer H., Gruetzner K.U., Babic R., Jauch K.W., and Schildberg F.W. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer. Ann Surg 226 6 (1997) 736-744
12. Macadam R., Sarela A., Wilson J., MacLennan K., and Guillou P. Bone marrow micrometastases predict early post-operative recurrence following surgical resection of oesophageal and gastric carcinoma. Eur J Surg Oncol 29 5 (2003) 450-454
13. Gretschel S., Schick C., Schneider U., Estevez-Schwarz L., Bembenek A., and Schlag P.M. Prognostic value of cytokeratin-positive bone marrow cells of gastric cancer patients. Ann Surg Oncol 14 2 (2007) 373-380
14. Yonemura Y., Fushida S., Bando E., et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 37 7 (2001) 918-923
15. Juttner S., Wissmann C., Jons T., et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 24 2 (2006) 228-240
16. Maehara Y., Hasuda S., Abe T., et al. Tumour angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer. Clin Cancer Res 4 9 (1998) 2129-2134
17. Spence G.M., Graham A.N., Mulholland K., et al. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer. Ann Thorac Surg 78 6 (2004) 1944-1949
18. Kakeji Y., Maehara Y., Shibahara K., et al. Clinical significance of micrometastasis in bone marrow of patients with gastric cancer and its relation to angiogenesis. Gastric Cancer 2 (1999) 46-51
19. Matsunami K., Nakamura T., Oguma H., Kitamura Y., and Takasaki K. Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation. Ann Surg Oncol 10 2 (2003) 171-175
20. Remmele W., and Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologie 8 3 (1987) 138-140
21. Fox S.B., Leek R.D., Bliss J., et al. Association of tumour angiogenesis with bone marrow micrometastases in breast cancer patients. J Natl Cancer Inst 89 14 (1997) 1044-1049
22. Nakamura T., Matsunami K., Hayashi K., Ota M., Ide H., and Takasaki K. Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation. Oncol Rep 11 5 (2004) 999-1003
23. Nagy J.A., Vasile E., Feng D., et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196 11 (2002) 1497-1506
24. Hong Y.K., Lange-Asschenfeldt B., Velasco P., et al. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J 18 10 (2004) 1111-1113
25. Maehara Y., Kabashima A., Koga T., et al. Vascular invasion and potential for tumour angiogenesis and metastasis in gastric carcinoma. Surgery 128 3 (2000) 408-416
26. Takahashi Y., Cleary K.R., Mai M., et al. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2 10 (1996) 1679-1684
27. Stacker S.A., Caesar C., Baldwin M.E., et al. VEGF-D promotes the metastatic spread of tumour cells via the lymphatics. Nat Med 7 2 (2001) 186-191
28. Ishikawa M., Kitayama J., Kazama S., and Nagawa H. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol 33 1 (2003) 21-27
29. Ichikura T., Tomimatsu S., Ohkura E., et al. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol 78 2 (2001) 132-137
30. Yonemura Y., Endo Y., Fujita H., et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5 7 (1999) 1823-1829
31. Amioka T., Kitadai Y., Tanaka S., et al. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 38 10 (2002) 1413-1419
32. Takahashi H., and Kondo T. Development of antiangiogenic chemotherapy regimens. Nippon Geka Gakkai Zasshi 103 2 (2002) 237-243
33. Karpanen T., Egeblad M., Karkkainen M.J., et al. Vascular endothelial growth factor C promotes tumour lymphangiogenesis and intralymphatic tumour growth. Cancer Res 61 5 (2001) 1786-1790